Watch past educational presentations and see live events in real time
Reference our medication guides for helpful information
Apply for the 2019 ACR/ARP Annual Meeting FIT Scholarship. The deadline is July 31.
Make a choice that matters
The best care starts with the best information
Encourage your rheumatology fellows-in-training to apply for the 2019 ACR/ARP Annual Meeting FIT Scholarship. The deadline to apply is July 31.
These pages contain background information on some of the most common medications and therapies used to treat rheumatic disease, such as how they work, common dosages, safety tips, possible side effects, risks and things you should discuss with your health care providers if you are taking or considering these treatments.
Spanish versions are available for most of the treatment pages. See the full list of treatments in Spanish or go to the English page and click the link on the right side of the page.
This information is for general education only. Please consult your rheumatologist for medical advice, diagnosis and treatment of your unique medical condition. For more details on how working with a rheumatologist can help you live well with rheumatic disease, read our article on the importance of following your treatment plan.
Allopurinol (Zyloprim, Aloprim) (new)
Belimumab (Benlysta) (new)
Canakinumab (Ilaris) (new)
Certolizumab pegol (Cimzia)
Colchicine (Colcrys, Mitigare) (new)
Cyclosporine (Neoral, Sandimmune, Gengraf)
Febuxostat (Uloric) (new)
Golimumab (Simponi Aria, Simponi)
Intravenous Immunoglobulin (IVIG) (new)
Intravenous (IV) Methylprednisolone (Solu-medrol) (new)
Ixekizumab (Taltz) (new)
Lesinurad (Zurampic) (new)
Methotrexate (Rheumatrex, Trexall)
Mycophenolate Mofetil & Mycophenolate Sodium
Pegloticase (Krystexxa) (new)
Rituximab (Rituxan & MabThera)
Rilonacept (Arcalyst) (new)
Sarilumab (Kevzara) (new)
Tofacitinib Citrate (Xeljanz)